NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM1525044 Query DataSets for GSM1525044
Status Public on May 11, 2015
Title Input_Replicate_3
Sample type SRA
 
Source name HEK-293FT
Organism Homo sapiens
Characteristics cell line: HEK-293FT
antibody: none
Growth protocol 2.1 million HEK293FT cells were plated on gelatinized 10 cm plates in high glucose Dulbecco’s modified Eagle’s medium (DMEM, Gibco), supplemented with 10% FBS, 1x penicillin/streptomycin and 2 mM L–Glutamine (Gibco). Cells were grown at 37°C and 5% CO2 in a humidified incubator. Cells were transfected one day later with plasmids expression dCas9 and the sgRNA plasmid pool, using Lipofectamine 2000 (Life Technologies), following the manufacturer's protocol. Cells were harvested three days later.
Extracted molecule total RNA
Extraction protocol Growth media was collected, and cells were washed twice with 10 mL of room temperature PBS (Gibco). Cells were crosslinked by incubation in 0.1% (v/v) formaldehyde in PBS for 10 minutes at room temperature, under very gentle agitation. Crosslinking was quenched by the addition of Glycine to 133 mM and gentle agitation for an additional five minutes at room temperature. The liquid phase was then aspirated; cells were washed twice with room temperature PBS, harvested by scraping, allotted into samples of 1×10^7 cells (typically three samples per 10 cm dish), and pelleted at 200 g in a swinging bucket rotor. PBS was aspirated and cell pellets were flash-frozen in liquid nitrogen and stored at –80°C until use. Cell pellets were thawed on ice, resuspended into 1 mL of ice-cold RIPA(+) buffer (standard RIPA supplemented with 0.1 U/uL RNAseOUT (Life Technologies), 1x EDTA-free Proteinase Inhibitor Cocktail (Thermo Scientific) and 0.5 mM DTT), and lysed for 10 minutes at 4°C with end-over-end agitation. Samples were then sheared using a Branson Digital Sonifier 250 (Emerson Industrial Automation) at 10% amplitude for three 30-second intervals (0.7 seconds on + 1.3 seconds off), with 30-second resting steps between intervals. Samples were held in ice-cold metal thermal blocks throughout sonication. Sheared samples were then clarified by ultracentrifugation and diluted with 1 mL each of ice-cold Native Lysis Buffer(+) (25 mM Tris, pH 7.4, 150 mM KCl, 5 mM ETA, 0.5% (v/v) NP-40, supplemented with inhibitors and DTT, as above), filtered through a 0.45 um syringe-mounted filter, and flash-frozen in liquid nitrogen before use. Clarified lysates were thawed on ice and pre-cleared by incubation with buffer-equilibrated magnetic Protein G beads (Life Technologies) for 30 minutes at 4°C, with end-over-end rotation. Cleared lysates corresponding to 5×10^6 cells were then incubated with 6 ug rabbit anti-FLAG antibody (SIGMA) or Rabbit normal IgG (Cell Signaling Technology), for two hours at 4°C with end-over-end rotation. Buffer-equilibrated magnetic Protein G beads were then added and the samples were again rotated end-over-end for one hour at 4°C. Resin was collected and twice washed with Native Lysis Buffer(+) for 10 minutes at 4°C, with end-over-end rotation. Beads were suspended in 56 μL nuclease-free water, and processed alongside input samples (56 μL; 5.6% of the total). All samples were brought to 100 μL in 1x PBS, 2% N-Lauroyl Sarcosine, 10 mM EDTA, 5 mM DTT, 0.4 U/μL RNaseOUT and 2 mg/mL proteinase K (Ambion), final. Formaldehyde crosslinks were reversed by incubation at 42°C for one hour, and then 55°C for one hour, in a thermocycler. RNA was purified using four volumes (400 μL) Agencourt RNAClean XP Beads (Beckman Coulter), following the manufacturer’s protocol, and eluted into 30 μL nuclease-free water. Residual DNA was removed by treatment with 5 U RNase-free DNAs (RQ1, Promega) in 50 μL, following the manufacturer’s protocol. RNA was subsequently purified using four volumes (200 μL) Agencourt RNAClean XP beads, eluted into 20 μL nuclease-free water.
Sample 1. Five ng of template DNA was PCR amplified using Pfu Ultra II HS polymerase (Agilent), according to the manufacterer's protocol, using gene-spectific primers appended with standard Illumina adapters and multiplexing indexes. The reaction volume was 50 uL; PCR was performed over 19 cycles. Samples 2–7. Twenty ng of RNA was reverse-transcribed using SuperScript III Reverse-transcriptase (Life Technologies) and a gene specific primer, in 20 uL, following the manufacturer's protocol. cDNA was then amplified over 26 cycles of PCR, in 200 uL reactions, using primers as described for Sample 1. All libraries were putified twice with Agencourt RNAClean XP beads, and eluted into 30 μL nuclease-free water.
 
Library strategy RIP-Seq
Library source transcriptomic
Library selection other
Instrument model Illumina HiSeq 2500
 
Data processing Sequence Identification: Random sequences were extracted from raw fastq files by trimming leading and trailing known sequences from each individual read.
Sequence Counts: Random sequences from all samples were pooled and condensed into a list of unique sequences. Occurrences of each sequence within individual samples was then tabulated.
Sequence Enrichment: Enrichment was determined using DESeq2.
Genome_build: N/A
Supplementary_files_format_and_content: Tab-delimited files containing random sequences and occurrences per sample.
 
Submission date Oct 14, 2014
Last update date May 15, 2019
Contact name Scott T Younger
E-mail(s) styounger@cmh.edu
Organization name Children's Mercy Kansas City
Street address 2401 Gillham Road
City Kansas City
State/province MO
ZIP/Postal code 64108
Country USA
 
Platform ID GPL16791
Series (2)
GSE62305 CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RIP-Seq]
GSE66756 CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo
Relations
BioSample SAMN03107079
SRA SRX732503

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap